Michael Schowalter
Overview
Explore the profile of Michael Schowalter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geskin L, Akilov O, Kwon S, Schowalter M, Watkins S, Whiteside T, et al.
Cancer Immunol Immunother
. 2017 Dec;
67(3):423-434.
PMID: 29204699
Tumor progression is associated with progressive immunosuppression mediated in part by T regulatory cell(s) (Treg) and/or myeloid-derived suppressor cell(s) (MDSC). Development of strategies to reduce populations of immune cells with...
2.
Stiegel E, Lam C, Schowalter M, Somani A, Lucas J, Poblete-Lopez C
Dermatol Surg
. 2017 Sep;
44(2):193-197.
PMID: 28857942
Background: The pathology observed on initial biopsy specimens for nonmelanoma skin cancer (NMSC), specifically the tumor subtype, weighs heavily into the selection of the treatment modality. Recognizing aggressive features on...
3.
Jacobson C, Sun L, Kim H, McDonough S, Reynolds C, Schowalter M, et al.
Biol Blood Marrow Transplant
. 2014 Jan;
20(5):668-75.
PMID: 24462743
Excessive levels of B cell activating factor (BAFF) are found in patients with active chronic graft-versus-host disease (cGVHD). In mice, BAFF has been shown to be essential for B cell...
4.
Silvers R, Smith J, Schowalter M, Litwin S, Liang Z, Geary K, et al.
Hum Gene Ther
. 2009 Nov;
21(3):337-49.
PMID: 19877879
HIV-1-based lentiviral vectors are a promising tool for gene therapy. However, integration of a lentiviral vector into host cell genes may lead to the development of cancer. Therefore, control of...
5.
Sarantopoulos S, Stevenson K, Kim H, Cutler C, Bhuiya N, Schowalter M, et al.
Blood
. 2009 Jan;
113(16):3865-74.
PMID: 19168788
Chronic graft-versus-host disease (cGVHD) causes significant morbidity and mortality in patients otherwise cured of malignancy after hematopoietic stem cell transplantation (HSCT). The presence of alloantibodies and high plasma B cell-activating...